Vancomycin in ICU Patients with Gram-Positive Infections: Initial Trough Levels and Mortality

BACKGROUND: Vancomycin is one of the most common therapeutic agents for treating gram-positive infections, particularly in critically ill patients. The aim of this study was to identify factors associated with initial therapeutic vancomycin trough levels and mortality in a tertiary-care intensive ca...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ther Clin Risk Manag
Egile Nagusiak: Alshehri, Nadiyah, Ahmed, Anwar E, Yenugadhati, Nagarajkumar, Javad, Sundas, Al Sulaiman, Khalid, M Al-Dorzi, Hasan, Aljerasiy, Majed, Badri, Motasim
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove 2020
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7569025/
https://ncbi.nlm.nih.gov/pubmed/33116547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S266295
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak